Thompson Street Capital Partners Completes Growth Investment In Sabai Global

Feb 06, 2023•over 2 years ago

ChesterfieldBiotechnologyHealth Care

Investors

Thompson Street Capital Partners

Description

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today a growth investment in Sabai Global (“Sabai”), a Chesterfield, MO based provider of regulatory review and biosafety consulting services to pharmaceutical sponsors, CROs, academic health systems, and clinical research site networks. Terms of the transaction were not disclosed.

Company Information

Company

Sabai Global

Location

Chesterfield, Virginia, United States

About

Sabai Global specializes in custom solutions for biosafety and human research protections through three subsidiaries – Clinical Biosafety Solutions (“CBS”), Castle IRB (“Castle”), and Shield Consulting (“Shield”). CBS provides Institutional Biosafety Committee services supporting the safe handling and storage of cell and gene therapy treatments during clinical research. Castle provides Institutional Review Board services supporting the ethical treatment of patients during clinical trials. Shield provides a suite of biosafety consulting services that complement CBS’s Institutional Biosafety Committee and Castle IRB’s offerings. Sabai was founded in 2017 and is headquartered in Chesterfield, MO.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers